Skip to content
10-Q

Quarterly Report

DIAMEDICA THERAPEUTICS INC. DMAC

0001437749-25-026207

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 51.69M sh
Capex Q2 2025 · Jun 30, 2025 $18K
Capex Q2 2025 · Jun 30, 2024 $9K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$14.75M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$11.17M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $4.11M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $3.03M
Stockholders Equity Q2 2025 · Jun 30, 2025 $27.17M
Stockholders Equity Q2 2025 · Mar 31, 2025 $33.95M
Stockholders Equity Q2 2025 · Dec 31, 2024 $40.72M
Stockholders Equity Q2 2025 · Jun 30, 2024 $53.42M
Stockholders Equity Q2 2025 · Mar 31, 2024 $46.35M
Stockholders Equity Q2 2025 · Dec 31, 2023 $51.06M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.12M
Current Liabilities Q2 2025 · Dec 31, 2024 $5.39M
Current Assets Q2 2025 · Jun 30, 2025 $31.08M
Current Assets Q2 2025 · Dec 31, 2024 $44.61M
Total Assets Q2 2025 · Jun 30, 2025 $31.47M
Total Assets Q2 2025 · Dec 31, 2024 $46.35M
Eps Basic Q2 2025 · Jun 30, 2025 −$0.18
Eps Basic Q2 2025 · Jun 30, 2025 −$0.36
Eps Basic Q2 2025 · Jun 30, 2024 −$0.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.27
Sga Expense Q2 2025 · Jun 30, 2025 $2.19M
Sga Expense Q2 2025 · Jun 30, 2025 $4.67M
Sga Expense Q2 2025 · Jun 30, 2024 $1.71M
Sga Expense Q2 2025 · Jun 30, 2024 $3.78M
Rd Expense Q2 2025 · Jun 30, 2025 $5.82M
Rd Expense Q2 2025 · Jun 30, 2025 $11.48M
Rd Expense Q2 2025 · Jun 30, 2024 $3.93M
Rd Expense Q2 2025 · Jun 30, 2024 $7.6M
Net Income Q2 2025 · Jun 30, 2025 −$7.7M
Net Income Q2 2025 · Jun 30, 2025 −$15.41M
Net Income Q2 2025 · Mar 31, 2025 −$7.71M
Net Income Q2 2025 · Jun 30, 2024 −$5.12M
Net Income Q2 2025 · Jun 30, 2024 −$10.27M
Net Income Q2 2025 · Mar 31, 2024 −$5.15M
Operating Income Q2 2025 · Jun 30, 2025 −$8.01M
Operating Income Q2 2025 · Jun 30, 2025 −$16.15M
Operating Income Q2 2025 · Jun 30, 2024 −$5.64M
Operating Income Q2 2025 · Jun 30, 2024 −$11.38M